|
UTRN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.89679999999771E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.190700E-04 |
| Normal-vs-Stage2 |
1.260830E-03 |
| Normal-vs-Stage3 |
1.162300E-04 |
| Normal-vs-Stage4 |
2.442500E-03 |
| Stage1-vs-Stage2 |
3.448600E-01 |
| Stage1-vs-Stage3 |
2.812600E-01 |
| Stage1-vs-Stage4 |
5.886600E-01 |
| Stage2-vs-Stage3 |
8.750000E-01 |
| Stage2-vs-Stage4 |
7.349600E-01 |
| Stage3-vs-Stage4 |
8.000600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.782830E-04 |
| Normal-vs-AfricanAmerican |
2.688800E-01 |
| Normal-vs-Asian |
3.639000E-03 |
| Caucasian-vs-AfricanAmerican |
1.848790E-01 |
| Caucasian-vs-Asian |
8.425600E-01 |
| AfricanAmerican-vs-Asian |
2.242400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.89150000004823E-06 |
| Normal-vs-Female |
6.221400E-04 |
| Male-vs-Female |
1.291840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.856600E-03 |
| Normal-vs-Age(41-60Yrs) |
3.52240000000004E-05 |
| Normal-vs-Age(61-80Yrs) |
2.989500E-04 |
| Normal-vs-Age(81-100Yrs) |
7.782800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.528200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.650850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.510440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.915800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.902000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.246000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.963800E-01 |
| Classical-VS-Follicular |
2.81489999998108E-06 |
| Classical-VS-Other |
1.602190E-01 |
| Classical-VS-Normal |
7.081900E-03 |
| Tall-VS-Follicular |
3.543600E-02 |
| Tall-VS-Other |
2.187000E-01 |
| Tall-VS-Normal |
1.363750E-02 |
| Follicular-VS-Other |
9.497200E-01 |
| Follicular-VS-Normal |
2.92030000181853E-08 |
| Other-VS-Normal |
1.645680E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.09290000000129E-06 |
| Normal-vs-N1 |
1.408330E-02 |
| N0-vs-N1 |
3.732200E-01 |
|
|
